Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabbit ATG plus ciclosporin in acquired aplastic anaemia
2007-000902-55Phase 2Completed
- Sponsor
- EBMT
- Start
- Jun 2007
- Modality
- Small Molecules, Peptides, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of antithymocyte globulin and cyclosporine in aplastic anemia (2 arms), sponsored by EBMT. Primary endpoint: Response at 6 months post treatment. Started Jun 2007; status: completed.
02
Drugs
antithymocyte globulincyclosporine
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on 2007-000902-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000902-55.